Abstract A248: integrated therapeutic antibody development at the National Research Council of Canada

From National Research Council Canada

DOIResolve DOI: https://doi.org/10.1158/1535-7163.TARG-13-A248
AuthorSearch for: 1 ; Search for: 1 ; Search for: 1 ; Search for: 1 ; Search for: 1 ; Search for: 1 ; Search for: 1 ; Search for: 1 
Name affiliation
  1. National Research Council Canada. Human Health Therapeutics
FormatText
TypeArticle
Journal titleMolecular Cancer Therapeutics
ISSN1535-7163
1538-8514
Volume12
Issue11 Supplement
PagesA248A248
Abstract
Publication date
PublisherAmerican Association for Cancer Research
LanguageEnglish
Peer reviewedYes
NPARC number23001783
Export citationExport as RIS
Report a correctionReport a correction
Record identifier48620866-e604-46da-927c-8af3a64ad827
Record created2017-04-06
Record modified2017-04-06
Date modified: